Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carole Ho Insider Profile
4 Followers
Carole Ho, CMO at Denali Therapeutics, holds 351.82K shares in Denali Therapeutics (Ticker: DNLI), holds ― shares in NGM Biopharmaceuticals (Ticker: NGM), holds ― shares in Beam Therapeutics (Ticker: BEAM).
Profitable Transactions
16 out of 17 Profitable Transactions
Average Return
+17.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Carole Ho holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 16, 2021 - Feb 16, 2022
Return:+44.30%
The most profitable trade made by Carole Ho
Carole Ho's Trading History
Denali Therapeutics
Feb 15, 2024
CMO
Uninformative Sell
24.99K
$5.93M
NGM Biopharmaceuticals
―
―
―
―
Beam Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Carole Ho's performance on stock
You May Also Like
Carole Ho insider profile FAQ
What is the percentage of profitable transactions made by Carole Ho?
The percentage of profitable transactions made by Carole Ho is 94%.
What is the average return per transaction made by Carole Ho?
The average return per transaction made by Carole Ho is 17.00%.
What stocks does Carole Ho hold?
Carole Ho holds: DNLI, NGM, BEAM stocks.
What was Carole Ho’s latest transaction?
Carole Ho latest transaction was an Uninformative Sell of $24.99K.
What was Carole Ho's most profitable transaction?
Carole Ho’s most profitable transaction was an Informative Sell of DNLI stock on February 16, 2021. The return on the trade was 44.30%.
What is Carole Ho's role in Denali Therapeutics?
Carole Ho's role in Denali Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.